Abstract
Obstructive sleep apnea (OSA) is a state of sleep disorder, characterized by repetitive episodes of apnea and chronic intermittent hypoxia. OSA has an extremely high prevalence worldwide and represents a serious challenge to public health, yet its severity is frequently underestimated. It is now well established that neurocognitive dysfunction, manifested as deficits in attention, memory, and executive functions, is a common complication observed in patients with OSA, whereas the specific pathogenesis remains poorly understood, despite the likelihood of involvement of inflammation. Here, we provide an overview of the current state of the art, demonstrating the intimacy of OSA with inflammation and cognitive impairment. Subsequently, we present the recent findings on the investigation of gut microbiota alteration in the OSA conditions, based on both patients-based clinical studies and animal models of OSA. We present an insightful discussion on the role of changes in the abundance of specific gut microbial members, including short-chain fatty acid (SCFA)-producers and/or microbes with pathogenic potential, in the pathogenesis of inflammation and further cognitive dysfunction. The transplantation of fecal microbiota from the mouse model of OSA can elicit inflammation and neurobehavioral disorders in naïve mice, thereby validating the causal relationship to inflammation and cognitive abnormality. This work calls for greater attention on OSA and the associated inflammation, which require timely and effective therapy to protect the brain from irreversible damage. This work also suggests that modification of the gut microbiota using prebiotics, probiotics or fecal microbiota transplantation may represent a potential adjuvant therapy for OSA.
Introduction
Obstructive sleep apnea (OSA) is a chronic sleep-related breathing disorder that is characterized by recurrent collapses in the upper airway during sleep, directly causing sleep fragmentation (SF) and chronic intermittent hypoxemia (IH) (Lévy et al., 2015). The development of OSA is largely attributed to a narrow, high-arched hard palate, or midface hypoplasia with retro-positioning of the maxilla and chin, or an enlarged pharynx, in the majority of cases observed in individuals with obesity (Neelapu et al., 2017; Kubota et al., 2005). The structural disproportions would in turn bring the soft palate and tongue closer to the back of the throat, thus leading to partial or complete airway blockage. Apnea hypopnea index (AHI), which is defined as an average number of partial or full breathing stop events within an hour of sleep, is the most common used indicator for the OSA diagnosis and severity determination (Shahar, 2014; Pevernagie et al., 2020). A number of epidemiological studies based on AHI have revealed a high prevalence of OSA globally (Benjafield et al., 2019; Grote, 2019; Wei et al., 2022; Lv et al., 2023). Two consecutive works have demonstrated that the OSA incidence in the adult population of the USA is approximately 33% among males but lower among females (Benjafield et al., 2019). The overall prevalence of OSA among 38,000 Russian citizens is 48.9% (Khokhrina et al., 2020). Notably, studies covering China (Ding et al., 2022), Chile (Peñafiel et al., 2019), Canada (Dosman et al., 2022), Germany (Fietze et al., 2019), Switzerland (Heinzer et al., 2015), Singapore (Tan et al., 2016), and Japan (Nakayama-Ashida et al., 2008) revealed a higher incidence of OSA, all of them exceeding 50%. Therefore, these findings collectively indicate that OSA is the most prevalent disease diagnosed in the department of otorhinolaryngology. The typical symptoms of OSA often include snoring, breathing breaks, excessive daytime sleepiness, and dry mouth and headache upon waking (Veasey and Rosen, 2019; Gottlieb and Punjabi, 2020). More importantly, prolonged exposure of OSA patients to IH could activate systematic inflammation and impact central nervous system (CNS), which ultimately lead to brain structural injury and severe neurocognitive deficits. The precise mechanism by which inflammation is induced in the OSA condition remains poorly understood.
Herein, we provide an overview of the current state of the art, and discuss a hypothetical scenario in which OSA may directly alter the composition of the gut microbiota, elicit inflammatory responses, and consequently lead to neurocognitive impairment. This paper reviews progress from both clinical studies and animal models are included.
Neurocognitive dysfunction is prevalent in OSA
Recent decades have borne witness to an increasing clarity regarding the prevalence of neurocognitive dysfunction among patients diagnosed with OSA. This phenomenon is characterized by deficits in attention, memory, and executive functions (Vanek et al., 2020; Xia et al., 2023; Kloepfer et al., 2009; Bawden et al., 2011; Hrubos-Strøm et al., 2012; Shieu et al., 2022). Indeed, clinical studies focusing on the effects of OSA have found that three distinct types of memory, including verbal, procedural and working memory, significantly decayed in the patients with OSA (Cunningham et al., 2023; Teh et al., 2023; Kloepfer et al., 2009; Naëgelé et al., 2006). Furthermore, several studies employed a more comprehensive set of tools to systematically identify cognitive impairment relevant to OSA (Xia et al., 2023; Bawden et al., 2011; Gnoni et al., 2023). Reviews of high quality are recommended to be consulted for a more detailed account of the cognitive impairment caused by OSA. This relatively underdiagnosed syndrome affects approximately 1 billion people globally and represents a significant public health concern (Benjafield et al., 2019).
In alignment with the abnormal cognitive function, structural alterations in brain tissues or regions have been identified through the utilization of diverse imaging technologies such as resting-state functional magnetic resonance imaging (fMRI) and computed tomography (CT). The affected areas across studies are diverse and often involved with multiple subregions (Zimmerman and Aloia, 2006), including the integrity of the gray or white matter (Lee et al., 2022; Castronovo et al., 2014), hippocampus (Kheirandish-Gozal et al., 2018; Macey et al., 2018; Gale and Hopkins, 2004), frontal lobe (Bai et al., 2021; Shu et al., 2022), temporal lobe (Shu et al., 2022; Morrell et al., 2010), cerebellum (Shu et al., 2022, Morrell et al., 2010), corpus callosum (Kheirandish-Gozal et al., 2018), and insular cortex (Kheirandish-Gozal et al., 2018). Despite the complexity and diversity, most of these areas are responsible for neurocognitive performance, indicating that structural alteration is a probable underlying cause of the observed deterioration in neurocognitive performance. For example, changes in the hippocampal volume have been identified in multiple studies through the MRI-based imaging analysis, while the hippocampus apoptosis or atrophy can cause learning, mnemonic, attentional, and executive function deficits. An early study, which involved with 17 newly diagnosed, untreated OSA patients and 15 age-matched healthy control subjects found that neurocognitive impairments were linked with a reduction of gray matter volume in the left hippocampus (entorhinal cortex), left posterior parietal cortex, and right superior frontal gyrus (Canessa et al., 2011). In another similar investigation, researchers identified atrophy of the neocortex and cerebellum, as well as a reduction in the volume of the hippocampal dentate gyrus and cerebellar dentate nucleus in patients with OSA (Kim H. et al., 2016). Of particular interest, after the continuous positive airway pressure (CPAP) treatment was administered to the patient cohorts in both studies, the impaired brain structure was restored to normality together with improved cognitive function, indicative of the reversibility of cognition deficits.
The intimate association of OSA with neurocognitive dysfunction has been also observed in a range of animal models, including pigs (Lonergan et al., 1998), dogs (Hendricks et al., 1993; Hendricks et al., 1987), rabbits (Schiefer et al., 2020; Yu et al., 2014), cats (Neuzeret et al., 2011), rats (Nácher et al., 2007; Farré et al., 2003), and mice (Qiu et al., 2023; Puech et al., 2022; Veasey et al., 2013; Nair et al., 2011a; Zhu et al., 2007; Puech et al., 2023). The disease has been modeled using either sleep fragmentation (SF), or intermittent hypoxia (IH), or both. SF can be induced by sleep disruption with experimental devices (Nair et al., 2011b; Ramesh et al., 2012), while IH is triggered by repeated exposure to lower oxygen levels (Badran et al., 2020; Puech et al., 2022). Although adverse effects of IH and SF on cognitive function may differ, common outcomes include impaired sleep quality, abnormal behavior, reduced learning ability and impaired physical functioning. In a study based on a rat model of OSA, for example, exposure to IH resulted in deficits in spatial memory and learning performance as assessed by Morris water maze tasks, together with the hippocampal apoptosis (Gao et al., 2017).
Inflammation caused by OSA is very likely to induce cognitive deficits
The pathogenesis of cognitive impairment induced by OSA is believed to be complex and remains poorly elucidated (Lv et al., 2023; Liu et al., 2020; Orrù et al., 2020). However, several lines of evidence from both clinical and animal model studies strongly support involvement of inflammation. Firstly, numerous studies have found that OSA can cause a systematic or local inflammation, as evidenced by increased levels of serum inflammatory cytokines are often observed in OSA patients (Liu et al., 2020; Nadeem et al., 2013; Bouloukaki et al., 2017; Bozic et al., 2018; Motamedi et al., 2018; Svatikova et al., 2003; Sozer et al., 2018). Tumor necrosis factor (TNF)-α and interleukin (IL)-6 are two representative biomarkers that are closely linked with OSA (Kheirandish-Gozal and Gozal, 2019), and more intriguingly both are also thought to contribute to neurocognitive dysfunction (Tegeler et al., 2016). Secondly, it is frequently observed that the activation of inflammatory processes and cognitive deficits occur concurrently in a considerable number of rodent models of OSA induced by IH (Liu et al., 2020; Dong et al., 2018; Sapin et al., 2015; Shi et al., 2018; Snyder et al., 2017; Darnall et al., 2017; Kim et al., 2013; Smith S. M. et al., 2013; Deng et al., 2015). Thirdly, in clinical studies, the magnitude of inflammation, as indicated by serum levels of various inflammatory cytokines, is frequently correlated with the severity of OSA (Nadeem et al., 2013; Sozer et al., 2018; Bouloukaki et al., 2017; Bozic et al., 2018; Motamedi et al., 2018). For instance, a recent analysis involving 858 OSA patients and 190 matched controls demonstrated that the serum levels of uric acid and high-sensitivity C-reactive protein (hsCRP), two markers of inflammation, were elevated in the severe group compared to the mild group (Bouloukaki et al., 2017). Fourthly, effective OSA therapy by CPAP can improve neurocognitive performance and also reduce/resolve inflammation (Tichanon et al., 2016; Lu et al., 2017; Ohga et al., 2003; Kuramoto et al., 2009; Wu et al., 2010; Jin et al., 2017; Yokoe et al., 2003; Steiropoulos et al., 2009; Schiza et al., 2010). Altogether, ample evidence from these works substantiates the pivotal role of OSA-induced neuroinflammation in the pathogenesis of neuronal injury and subsequent cognitive deficits.
The precise mechanistic pathway by which OSA triggers inflammation remains poorly understood. However, it has been postulated that HIF-1α, a critical transcription factor responsive to hypoxic conditions, is activated to increase ROS synthesis, which would in turn initiate oxidative stress and the inflammatory process (McGettrick and O’Neill, 2020). Furthermore, there is also evidence to show that chronic IH conditions observed in OSA patients stimulate leptin, an obesity biomarker in white adipose tissue (Pan and Kastin, 2014), while leptin can further promote production of proinflammatory cytokines (Berger and Polotsky, 2018). These changes may further lead to monocyte-endothelial cell adhesion, dysfunction of endothelial cells, breach of the blood–brain barrier, and finally the perfusion of inflammatory cytokines and macrophages into the central nervous system. Consequently, the excessive neuroinflammatory response results in the activation of glial cells, synaptic damage and loss, neuronal necrosis and apoptosis, and ultimately a significant exacerbation of neurocognitive deficits (Liu et al., 2020).
OSA altered gut microbiota
In addition to the aforementioned effects on inflammation and cognitive function, the impact of OSA can even extend to the gastrointestinal tract to modulate the oxygen concentrations and further the ecosystem, where at least 100 trillion bacteria colonize (Honda and Littman, 2016; Rooks and Garrett, 2016; Gomaa, 2020). In light of the existence of an oxygen concentration gradient in the range of 150–200 μm near the gut epithelium (Espey, 2013) and the susceptible responsiveness of gut microbiota to oxygen level change (Albenberg et al., 2014), it seems highly probable that chronic exposure to hypoxia would favor the survival of obligate anaerobes and therefore alter the bacterial diversity. Indeed, several mouse model-based studies have demonstrated that IH intervention can induce a periodic hypoxia pattern in the arterial blood and the lumen of the small intestine, as well as an increased abundance of obligate and facultative anaerobes (Moreno-Indias et al., 2015; Khalyfa et al., 2021; Lucking et al., 2018; Durgan et al., 2016), despite the possibility that IH-induced systemic immune responses may exert a modulatory effect on gut microbiota. Another important feature of OSA is nocturnal arousal due to sleep fragmentation. Interestingly exposure of mice to sleep fragmentation also caused notable change in gut microbiota, characterized by an increase in Firmicutes and a decrease in Bacteroidetes at the phylum level (Poroyko et al., 2016). It is noteworthy that a gut dysbiosis was also a prevalent trait in OSA patients. Two clinical studies investigating the OSA patients from disparate regions in China identified an altered gut microbiota profile (Ko et al., 2019; Wang et al., 2022). Furthermore, the composition of the gut microbiota was found to be significantly altered in pediatric patients with OSA in comparison to their age-matched healthy controls (Valentini et al., 2020; Collado et al., 2019). Consistently, an interesting single-armed study that investigated the responses of nine normal-weight men under two occasions, either with two nights of normal sleep or two nights of partial sleep deprivation. It revealed that sleep loss can directly induce an increased Firmicutes to Bacteroides (F/B) ratio in gut microbiota (Benedict et al., 2016).
Gut microbiota composition alteration associated with inflammatory activation in OSA patients
In light of the pivotal roles of gut microbiota in regulating human physiology, particularly immunity (Kamada et al., 2012; Donohoe et al., 2011; Zheng et al., 2020; Belkaid and Harrison, 2017; Albhaisi et al., 2020; Morais et al., 2021), a hypothesis was therefore proposed that the OSA-induced gut dysbiosis, often featured with a changed F/B ratio, might contribute to inflammation, and potentially the cognitive dysfunction. In the context of the microbiota-immune system interaction, multiple microbial metabolites and components, including short-chain fatty acids (SCFAs), lipopolysaccharide (LPS) and exotoxins, act as potent effectors, facilitating a bridge between gut microbiota and local or systematic immunity (Rooks and Garrett, 2016; Wang G. et al., 2019). Indeed, the immunological effects of these microbiota-derived molecules are manifold, encompassing both innate and adaptive immunity (Tang et al., 2021). SCFAs are primarily produced from indigestible oligosaccharides by some beneficial members of the Bacteroidetes phylum, including the families Lactobacillaceae, Ruminococcaceae, Erysipelotrichaceae, Bifidobacteriaceae, and Clostridium (den Besten et al., 2013). In addition to serving as a source of energy for intestinal epithelial cells (IEC) (Rivière et al., 2016), SCFAs have pleotropic roles in the fortification of the gut barrier and maintenance of immune homeostasis. More specifically, these beneficial regulatory actions include stimulation of mucus production (Wrzosek et al., 2013), regulation of tight junction (TJ) proteins via multifaceted signaling pathways (Parada Venegas et al., 2019), polarization of anti-inflammatory macrophages (Ji et al., 2016), increased production of antimicrobial peptide (AMP) (Qiu et al., 2012), activation of NLR-family-pyrin-domain-containing-3 (NLRP3) inflammasomes and production of homeostatic cytokine interleukin-18 (IL-18) (Macia et al., 2015), modulation of B cell differentiation and Immunoglobulin A (IgA) secretion (Kim M. et al., 2016), reduced expression of T cell-activating molecules on antigen-presenting cells (Park et al., 2015), and increased number and function of colonic regulatory T (Tregs) cells (Smith P. M. et al., 2013). In contrast, several gut microbial members, including Desulfovibrio, Prevotella, Lachnospiraceae, and Paraprevotella, have been demonstrated to induce inflammatory responses and disrupt the structural integrity of the gut barrier. LPS is a well-known bacterial endotoxin with profound immunostimulatory and inflammatory capacity. Contrary to the beneficial effects of SCFAs, LPS has the potential to bind to its cognate toll-like-receptor (TLR4) and promote the activation of inflammatory macrophage (M1 polarization), which in turn leads to the production of an array of inflammatory cytokines, IL-1β, IL-6, IL-12, and TNF-α (Martinez et al., 2008). Through the same signal pathway, LPS can also compromise the integrity of the intestinal barrier (Guo et al., 2013). Furthermore, the prevalence of Prevotella and Desulfovibrio, which possess mucin-degrading capabilities, was found to be elevated in individuals with OSA, thereby exacerbating the gut permeability. An increase in those bacterial species will therefore cause the leakage of LPS and other bacterial components from the gut into the blood circulation, thus stimulating the release of inflammatory mediators and aggravating systemic inflammation.
Consistent with the above analysis, an investigation into the alteration of the gut microbiota in OSA patients indeed validated the abundance reduction in the abundance of bacteria associated with SCFA production, or alternatively an increase in the abundance of pathogenic ones, despite the fact that only a limited number of clinical studies in this direction existed. One study involving 93 OSA patients revealed that alterations in the gut microbiota were characterized by a decrease in the abundance of SCFA producers (including Faecalibacterium, Bifidobacterium, Lactobacillus, and Bacteroides), an increase for the pathogenic Prevotella, and concomitantly a reduction in the serum levels of IL-6 (Ko et al., 2019). Interestingly, this work did not identify a profound change in the F/B ratio between the OSA patients and healthy controls (Ko et al., 2019), suggesting that the F/B ratio alteration may not be a general OSA-associated rule, and that a more detailed analysis of specific bacterial taxa level should be necessary. In another observational study, the inflammation-related bacteria (Megamonas, Lactobacillus, Megasphaera, and Coprococcus at the genus level) were also enriched in OSA patients, while Alistipes, Eubacterium coprostanoligenes, Blautia, Roseburia, Fusobacteria, and Ruminococcus gnavus were found to be depleted. The pro-inflammatory cytokine IL-1β and TNF-α were elevated with OSA (Lu et al., 2022). A comparable pattern was identified among the pediatric OSA patients, whereby the relative abundances of several well-documented SCFA producers, including Bacteroides, Bifidobacterium, Ruminococcus, Collinsella, and Faecalibacterium, exhibited a decline (Valentini et al., 2020). The hypothesis was further validated in the two clinical trials, in which healthy human subjects were exposed to either a short-term or a long-term period of sleep deprivation, directly resulted in a reduction of the abovementioned species with SCFA-production capacity (Gao et al., 2023; Benedict et al., 2016).
Moreover, a comparable pattern was observed in multiple OSA animal model-based gut microfloral analyses, with an increase in pathogenic microbes being a particularly prevalent finding. For example, Prevotella, Paraprevotella, Desulfovibrio, and Lachnospiraceae were found to be enriched in a mouse model of OSA, induced by either SF or IH (Gao et al., 2023; Poroyko et al., 2016; Badran et al., 2020; Khalyfa et al., 2021; Badran et al., 2023; Yan et al., 2024). Interestingly, treatment of the sleep-deprived mice with butyrate, a type of SCFA, significantly ameliorated intestinal mucosa injury and inflammation response through the suppression of the HDAC3–GSK-3β–Nrf2–NF-κB signaling cascade (Gao et al., 2023). In another study, neonatal brain immaturity, white matter injury (WMI), reduced abundance of beneficial gut microbes Bacteroides thetaiotaomicron and Parabacteroides distasonis and accumulation of microbiota-derived cholic acid were identified in chronically hypoxic rats, whereas administration of B. thetaiotaomicron and P. distasonis reverted the cholic acid concentration and rescued the chronic hypoxia-induced WMI and inflammation. These findings suggest that the administration of SCFAs or probiotics may represent a potential strategy for alleviating the inflammation and neurocognitive deficits associated with OSA (Yan et al., 2024).
Fecal microbiota transplant (FMT) simply implies the transfer of stool samples from a donor’s colon to a recipient’s colon (Gupta and Khanna, 2017). FMT has demonstrated considerable promise in the treatment of intestinal infection, inflammatory bowel disease, hypertension, obesity, and diabetes mellitus (Kelly et al., 2015; Turnbaugh et al., 2006; Adnan et al., 2017; Wang H. et al., 2019). Although only a few studies have employed FMT in analyzing the basis of OSA, two recent works showed that FMT from the IH-mice can elicit inflammation and neurobehavioral disorders in naïve mice (Badran et al., 2020; Poroyko et al., 2016). This provides further robust evidence that gut microbiota dysbiosis is, at least partially, a causal basis of cognitive dysfunction.
Conclusions and perspectives
The prevalence of OSA is markedly high across countries and regions, and it is frequently complexed with a variety of comorbidities. With firm evidence from both clinical studies and animal models, the present review reveals a clear and compelling link of OSA with alterations in the gut microbiota, systematic inflammation, brain substructural changes and neurocognitive impairment, respectively. A hypothesis is therefore proposed to explain the pathogenesis of OSA that chronic IH or SF in OSA patients would trigger gut microbiota dysbiosis, which is often characterized by depletion of producers of beneficial microbial metabolites, or/and enrichment of microbes with potentials to impair mucosa and activate inflammation (Figure 1). This in turn results in the activation of systematic inflammation, with inflammatory cytokines breaching the blood–brain barrier, activating microglial cells, and ultimately causing necrosis and apoptosis of neural cells and neurocognitive deficits. It is imperative to emphasize the importance of timely diagnosis and treatment of OSA and its associated inflammation, in order to prevent or alleviate the irreversible neurocognitive damage. Moreover, the modulation of gut microbiota using prebiotics (such as butyrate), or probiotics (SCFA producers) may represent a potential and effective adjuvant therapy for OSA. More future works in this direction are still needed.
Figure 1
Statements
Author contributions
MT: Conceptualization, Funding acquisition, Investigation, Supervision, Writing – original draft, Writing – review & editing. YW: Data curation, Formal analysis, Writing – original draft. JL: Writing – original draft. SY: Data curation, Writing – original draft. ZH: Writing – original draft. JH: Writing – review & editing. QY: Writing – review & editing. FL: Writing – original draft. SL: Writing – original draft, Writing – review & editing.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was funded by the Medical Research Foundation of GuangDong Province (A2022046 and B2022097), the Outstanding Young Researcher program (NSZD2023011), the general project (2020072) and the key program (NS2022005) granted by the Science and Technology Key Research Program in Nanshan District Health Care System, the Shenzhen Science and Technology Innovation Commission for Research and Development Projects (JCYJ20210324112607020, JCYJ20220530141616037, and JCYJ20230807115827057), Shenzhen University ENT Discipline Development Project sponsored by Shenzhen Huaqiang Holdings Co., Ltd., and the GuangDong Basic and Applied Basic Research Foundation (2023A1515110855).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AdnanS.NelsonJ. W.AjamiN. J.VennaV. R.PetrosinoJ. F.BryanR. M.Jr.et al. (2017). Alterations in the gut microbiota can elicit hypertension in rats. Physiol. Genomics49, 96–104. doi: 10.1152/physiolgenomics.00081.2016
2
AlbenbergL.EsipovaT. V.JudgeC. P.BittingerK.ChenJ.LaughlinA.et al. (2014). Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology147, 1055–1063.e8. doi: 10.1053/j.gastro.2014.07.020
3
AlbhaisiS. A. M.BajajJ. S.SanyalA. J. (2020). Role of gut microbiota in liver disease. Am. J. Physiol. Gastrointest. Liver Physiol.318, G84–G98. doi: 10.1152/ajpgi.00118.2019
4
BadranM.KhalyfaA.EricssonA.GozalD. (2020). Fecal microbiota transplantation from mice exposed to chronic intermittent hypoxia elicits sleep disturbances in naïve mice. Exp. Neurol.334:113439. doi: 10.1016/j.expneurol.2020.113439
5
BadranM.KhalyfaA.EricssonA. C.PuechC.McadamsZ.BenderS. B.et al. (2023). Gut microbiota mediate vascular dysfunction in a murine model of sleep apnoea: effect of probiotics. Eur. Respir. J.61:2200002. doi: 10.1183/13993003.00002-2022
6
BaiJ.WenH.TaiJ.PengY.LiH.MeiL.et al. (2021). Altered spontaneous brain activity related to neurologic and sleep dysfunction in children with obstructive sleep apnea syndrome. Front. Neurosci.15:595412. doi: 10.3389/fnins.2021.595412
7
BawdenF. C.OliveiraC. A.CaramelliP. (2011). Impact of obstructive sleep apnea on cognitive performance. Arq. Neuropsiquiatr.69, 585–589. doi: 10.1590/s0004-282x2011000500003
8
BelkaidY.HarrisonO. J. (2017). Homeostatic immunity and the microbiota. Immunity46, 562–576. doi: 10.1016/j.immuni.2017.04.008
9
BenedictC.VogelH.JonasW.WotingA.BlautM.SchürmannA.et al. (2016). Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals. Mol. Metab.5, 1175–1186. doi: 10.1016/j.molmet.2016.10.003
10
BenjafieldA. V.AyasN. T.EastwoodP. R.HeinzerR.IpM. S. M.MorrellM. J.et al. (2019). Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir. Med.7, 687–698. doi: 10.1016/s2213-2600(19)30198-5
11
BergerS.PolotskyV. Y. (2018). Leptin and leptin resistance in the pathogenesis of obstructive sleep apnea: a possible link to oxidative stress and cardiovascular complications. Oxidative Med. Cell. Longev.2018:5137947. doi: 10.1155/2018/5137947
12
BouloukakiI.MermigkisC.TzanakisN.KallergisE.MoniakiV.MauroudiE.et al. (2017). Evaluation of inflammatory markers in a large sample of obstructive sleep apnea patients without comorbidities. Mediat. Inflamm.2017:4573756. doi: 10.1155/2017/4573756
13
BozicJ.BorovacJ. A.GalicT.KurirT. T.Supe-DomicD.DogasZ. (2018). Adropin and inflammation biomarker levels in male patients with obstructive sleep apnea: a link with glucose metabolism and sleep parameters. J. Clin. Sleep Med.14, 1109–1118. doi: 10.5664/jcsm.7204
14
CanessaN.CastronovoV.CappaS. F.AloiaM. S.MarelliS.FaliniA.et al. (2011). Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am. J. Respir. Crit. Care Med.183, 1419–1426. doi: 10.1164/rccm.201005-0693OC
15
CastronovoV.ScifoP.CastellanoA.AloiaM. S.IadanzaA.MarelliS.et al. (2014). White matter integrity in obstructive sleep apnea before and after treatment. Sleep37, 1465–1475. doi: 10.5665/sleep.3994
16
ColladoM. C.KatilaM. K.VuorelaN. M.Saarenpää-HeikkiläO.SalminenS.IsolauriE. (2019). Dysbiosis in snoring children: An interlink to comorbidities?J. Pediatr. Gastroenterol. Nutr.68, 272–277. doi: 10.1097/mpg.0000000000002161
17
CunninghamT. J.KishoreD.GuoM.IgueM.MalhotraA.StickgoldR.et al. (2023). The effect of obstructive sleep apnea on sleep-dependent emotional memory consolidation. Ann. Am. Thorac. Soc.20, 296–306. doi: 10.1513/AnnalsATS.202204-315OC
18
DarnallR. A.ChenX.NemaniK. V.SirieixC. M.GimiB.KnoblachS.et al. (2017). Early postnatal exposure to intermittent hypoxia in rodents is proinflammatory, impairs white matter integrity, and alters brain metabolism. Pediatr. Res.82, 164–172. doi: 10.1038/pr.2017.102
19
Den BestenG.Van EunenK.GroenA. K.VenemaK.ReijngoudD.-J.BakkerB. M. (2013). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res.54, 2325–2340. doi: 10.1194/jlr.R036012
20
DengY.YuanX.GuoX. L.ZhuD.PanY. Y.LiuH. G. (2015). Efficacy of atorvastatin on hippocampal neuronal damage caused by chronic intermittent hypoxia: involving tlr4 and its downstream signaling pathway. Respir. Physiol. Neurobiol.218, 57–63. doi: 10.1016/j.resp.2015.07.006
21
DingS.ZhangP.WangL.WangD.SunK.MaY.et al. (2022). Prevalence of obstructive sleep apnea syndrome in hospitalized patients with type 2 diabetes in Beijing, China. J. Diabetes Investig.13, 1889–1896. doi: 10.1111/jdi.13868
22
DongP.ZhaoJ.LiN.LuL.LiL.ZhangX.et al. (2018). Sevoflurane exaggerates cognitive decline in a rat model of chronic intermittent hypoxia by aggravating microglia-mediated neuroinflammation via downregulation of ppar-γ in the hippocampus. Behav. Brain Res.347, 325–331. doi: 10.1016/j.bbr.2018.03.031
23
DonohoeD. R.GargeN.ZhangX.SunW.O'connellT. M.BungerM. K.et al. (2011). The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab.13, 517–526. doi: 10.1016/j.cmet.2011.02.018
24
DosmanJ. A.KarunanayakeC. P.FentonM.RamsdenV. R.SeeseequasisJ.MikeD.et al. (2022). Stop-bang score and prediction of severity of obstructive sleep apnea in a first nation community in Saskatchewan, Canada. Clocks Sleep4, 535–548. doi: 10.3390/clockssleep4040042
25
DurganD. J.GaneshB. P.CopeJ. L.AjamiN. J.PhillipsS. C.PetrosinoJ. F.et al. (2016). Role of the gut microbiome in obstructive sleep apnea-induced hypertension. Hypertension67, 469–474. doi: 10.1161/hypertensionaha.115.06672
26
EspeyM. G. (2013). Role of oxygen gradients in shaping redox relationships between the human intestine and its microbiota. Free Radic. Biol. Med.55, 130–140. doi: 10.1016/j.freeradbiomed.2012.10.554
27
FarréR.RotgerM.MontserratJ. M.CaleroG.NavajasD. (2003). Collapsible upper airway segment to study the obstructive sleep apnea/hypopnea syndrome in rats. Respir. Physiol. Neurobiol.136, 199–209. doi: 10.1016/S1569-9048(03)00082-X
28
FietzeI.LaharnarN.ObstA.EwertR.FelixS. B.GarciaC.et al. (2019). Prevalence and association analysis of obstructive sleep apnea with gender and age differences – results of ship-trend. J. Sleep Res.28:e12770. doi: 10.1111/jsr.12770
29
GaleS. D.HopkinsR. O. (2004). Effects of hypoxia on the brain: neuroimaging and neuropsychological findings following carbon monoxide poisoning and obstructive sleep apnea. J. Int. Neuropsychol. Soc.10, 60–71. doi: 10.1017/S1355617704101082
30
GaoH.HanZ.HuangS.BaiR.GeX.ChenF.et al. (2017). Intermittent hypoxia caused cognitive dysfunction relate to mirnas dysregulation in hippocampus. Behav. Brain Res.335, 80–87. doi: 10.1016/j.bbr.2017.06.025
31
GaoT.WangZ.DongY.CaoJ.ChenY. (2023). Butyrate ameliorates insufficient sleep-induced intestinal mucosal damage in humans and mice. Microbiol. Spectr.11, e02000–e02022. doi: 10.1128/spectrum.02000-22
32
GnoniV.MesquitaM.O'reganD.DeloguA.ChakalovI.AntalA.et al. (2023). Distinct cognitive changes in male patients with obstructive sleep apnoea without co-morbidities. Front. Sleep2:1097946. doi: 10.3389/frsle.2023.1097946
33
GomaaE. Z. (2020). Human gut microbiota/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek113, 2019–2040. doi: 10.1007/s10482-020-01474-7
34
GottliebD. J.PunjabiN. M. (2020). Diagnosis and management of obstructive sleep apnea: a review. JAMA323, 1389–1400. doi: 10.1001/jama.2020.3514
35
GroteL. (2019). The global burden of sleep apnoea. Lancet Respir. Med.7, 645–647. doi: 10.1016/s2213-2600(19)30226-7
36
GuoS.Al-SadiR.SaidH. M.MaT. Y. (2013). Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of tlr-4 and cd14. Am. J. Pathol.182, 375–387. doi: 10.1016/j.ajpath.2012.10.014
37
GuptaA.KhannaS. (2017). Fecal microbiota transplantation. JAMA318:102. doi: 10.1001/jama.2017.6466
38
HeinzerR.VatS.Marques-VidalP.Marti-SolerH.AndriesD.TobbackN.et al. (2015). Prevalence of sleep-disordered breathing in the general population: the hypnolaus study. Lancet Respir. Med.3, 310–318. doi: 10.1016/s2213-2600(15)00043-0
39
HendricksJ. C.KlineL. R.KovalskiR. J.O'BrienJ. A.MorrisonA. R.PackA. I. (1987). The english bulldog: a natural model of sleep-disordered breathing. J. Appl. Physiol.63, 1344–1350. doi: 10.1152/jappl.1987.63.4.1344
40
HendricksJ. C.PetrofB. J.PanckeriK.PackA. I. (1993). Upper airway dilating muscle hyperactivity during non-rapid eye movement sleep in english bulldogs. Am. Rev. Respir. Dis.148, 185–194. doi: 10.1164/ajrccm/148.1.185
41
HondaK.LittmanD. R. (2016). The microbiota in adaptive immune homeostasis and disease. Nature535, 75–84. doi: 10.1038/nature18848
42
Hrubos-StrømH.NordhusI. H.EinvikG.RandbyA.OmlandT.SundetK.et al. (2012). Obstructive sleep apnea, verbal memory, and executive function in a community-based high-risk population identified by the berlin questionnaire Akershus sleep apnea project. Sleep Breath.16, 223–231. doi: 10.1007/s11325-011-0493-1
43
JiJ.ShuD.ZhengM.WangJ.LuoC.WangY.et al. (2016). Microbial metabolite butyrate facilitates M2 macrophage polarization and function. Sci. Rep.6:24838. doi: 10.1038/srep24838
44
JinF.LiuJ.ZhangX.CaiW.ZhangY.ZhangW.et al. (2017). Effect of continuous positive airway pressure therapy on inflammatory cytokines and atherosclerosis in patients with obstructive sleep apnea syndrome. Mol. Med. Rep.16, 6334–6339. doi: 10.3892/mmr.2017.7399
45
KamadaN.KimY. G.ShamH. P.VallanceB. A.PuenteJ. L.MartensE. C.et al. (2012). Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science336, 1325–1329. doi: 10.1126/science.1222195
46
KellyC. R.KahnS.KashyapP.LaineL.RubinD.AtrejaA.et al. (2015). Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology149, 223–237. doi: 10.1053/j.gastro.2015.05.008
47
KhalyfaA.EricssonA.QiaoZ.AlmendrosI.FarréR.GozalD. (2021). Circulating exosomes and gut microbiome induced insulin resistance in mice exposed to intermittent hypoxia: effects of physical activity. EBioMedicine64:103208. doi: 10.1016/j.ebiom.2021.103208
48
Kheirandish-GozalL.GozalD. (2019). Obstructive sleep apnea and inflammation: proof of concept based on two illustrative cytokines. Int. J. Mol. Sci.20:459. doi: 10.3390/ijms20030459
49
Kheirandish-GozalL.SahibA. K.MaceyP. M.PhilbyM. F.GozalD.KumarR. (2018). Regional brain tissue integrity in pediatric obstructive sleep apnea. Neurosci. Lett.682, 118–123. doi: 10.1016/j.neulet.2018.06.002
50
KhokhrinaA.AndreevaE.DegryseJ. M. (2020). The prevalence of sleep-disordered breathing in Northwest Russia: the arkhsleep study. Chron. Respir. Dis.17:1479973120928103. doi: 10.1177/1479973120928103
51
KimH.JooE.SuhS.KimJ. H.KimS. T.HongS. B. (2016). Effects of long-term treatment on brain volume in patients with obstructive sleep apnea syndrome. Hum. Brain Mapp.37, 395–409. doi: 10.1002/hbm.23038
52
KimS. M.KimH.LeeJ. S.ParkK. S.JeonG. S.ShonJ.et al. (2013). Intermittent hypoxia can aggravate motor neuronal loss and cognitive dysfunction in als mice. PLoS One8:e81808. doi: 10.1371/journal.pone.0081808
53
KimM.QieY.ParkJ.KimC. H. (2016). Gut microbial metabolites fuel host antibody responses. Cell Host Microbe20, 202–214. doi: 10.1016/j.chom.2016.07.001
54
KloepferC.RiemannD.NofzingerE. A.FeigeB.UnterrainerJ.O'HaraR.et al. (2009). Memory before and after sleep in patients with moderate obstructive sleep apnea. J. Clin. Sleep Med.5, 540–548. doi: 10.5664/jcsm.27655
55
KoC. Y.LiuQ. Q.SuH. Z.ZhangH. P.FanJ. M.YangJ. H.et al. (2019). Gut microbiota in obstructive sleep apnea-hypopnea syndrome: disease-related dysbiosis and metabolic comorbidities. Clin. Sci.133, 905–917. doi: 10.1042/cs20180891
56
KubotaY.NakayamaH.TakadaT.MatsuyamaN.SakaiK.YoshizawaH.et al. (2005). Facial axis angle as a risk factor for obstructive sleep apnea. Intern. Med.44, 805–810. doi: 10.2169/internalmedicine.44.805
57
KuramotoE.KinamiS.IshidaY.ShiotaniH.NishimuraY. (2009). Continuous positive nasal airway pressure decreases levels of serum amyloid a and improves autonomic function in obstructive sleep apnea syndrome. Int. J. Cardiol.135, 338–345. doi: 10.1016/j.ijcard.2008.03.078
58
LeeM. H.LeeS. K.KimS.KimR. E. Y.NamH. R.SiddiqueeA. T.et al. (2022). Association of obstructive sleep apnea with white matter integrity and cognitive performance over a 4-year period in middle to late adulthood. JAMA Netw. Open5, –e2222999. doi: 10.1001/jamanetworkopen.2022.22999
59
LévyP.KohlerM.McnicholasW. T.BarbéF.McevoyR. D.SomersV. K.et al. (2015). Obstructive sleep apnoea syndrome. Nat. Rev. Dis. Primers1:15015. doi: 10.1038/nrdp.2015.15
60
LiuX.MaY.OuyangR.ZengZ.ZhanZ.LuH.et al. (2020). The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome. J. Neuroinflammation17:229. doi: 10.1186/s12974-020-01905-2
61
LonerganR. P.WareJ. C.AtkinsonR. L.WinterW. C.SurattP. M. (1998). Sleep apnea in obese miniature pigs. J. Appl. Physiol.84, 531–536. doi: 10.1152/jappl.1998.84.2.531
62
LuD.LiN.YaoX.ZhouL. (2017). Potential inflammatory markers in obstructive sleep apnea-hypopnea syndrome. Bosn. J. Basic Med. Sci.17, 47–53. doi: 10.17305/bjbms.2016.1579
63
LuD.XuS.DaiP.WuL.ZhangH.ZhouB. (2022). Gut microbiota in hypertensive patients with versus without obstructive sleep apnea. J. Clin. Hypertens.24, 1598–1605. doi: 10.1111/jch.14598
64
LuckingE. F.O'connorK. M.StrainC. R.FouhyF.BastiaanssenT. F. S.BurnsD. P.et al. (2018). Chronic intermittent hypoxia disrupts cardiorespiratory homeostasis and gut microbiota composition in adult male guinea-pigs. EBioMedicine38, 191–205. doi: 10.1016/j.ebiom.2018.11.010
65
LvR.LiuX.ZhangY.DongN.WangX.HeY.et al. (2023). Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome. Signal Transduct. Target. Ther.8:218. doi: 10.1038/s41392-023-01496-3
66
MaceyP. M.PrasadJ. P.OgrenJ. A.MoiyadiA. S.AysolaR. S.KumarR.et al. (2018). Sex-specific hippocampus volume changes in obstructive sleep apnea. Neuroimage Clin.20, 305–317. doi: 10.1016/j.nicl.2018.07.027
67
MaciaL.TanJ.VieiraA. T.LeachK.StanleyD.LuongS.et al. (2015). Metabolite-sensing receptors gpr43 and gpr109a facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun.6:6734. doi: 10.1038/ncomms7734
68
MartinezF. O.SicaA.MantovaniA.LocatiM. (2008). Macrophage activation and polarization. Front. Biosci.13, 453–461. doi: 10.2741/2692
69
McgettrickA. F.O’NeillL. A. J. (2020). The role of hif in immunity and inflammation. Cell Metab.32, 524–536. doi: 10.1016/j.cmet.2020.08.002
70
MoraisL. H.SchreiberH. L.MazmanianS. K. (2021). The gut microbiota–brain axis in behaviour and brain disorders. Nat. Rev. Microbiol.19, 241–255. doi: 10.1038/s41579-020-00460-0
71
Moreno-IndiasI.TorresM.MontserratJ. M.Sanchez-AlcoholadoL.CardonaF.TinahonesF. J.et al. (2015). Intermittent hypoxia alters gut microbiota diversity in a mouse model of sleep apnoea. Eur. Respir. J.45, 1055–1065. doi: 10.1183/09031936.00184314
72
MorrellM. J.JacksonM. L.TwiggG. L.GhiassiR.McrobbieD. W.QuestR. A.et al. (2010). Changes in brain morphology in patients with obstructive sleep apnoea. Thorax65, 908–914. doi: 10.1136/thx.2009.126730
73
MotamediV.KanefskyR.MatsangasP.MithaniS.JerominA.BrockM. S.et al. (2018). Elevated tau and interleukin-6 concentrations in adults with obstructive sleep apnea. Sleep Med.43, 71–76. doi: 10.1016/j.sleep.2017.11.1121
74
NácherM.Serrano-MollarA.FarréR.PanésJ.SeguíJ.MontserratJ. M. (2007). Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea. Respir. Physiol. Neurobiol.155, 93–96. doi: 10.1016/j.resp.2006.06.004
75
NadeemR.MolnarJ.MadboulyE. M.NidaM.AggarwalS.SajidH.et al. (2013). Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J. Clin. Sleep Med.9, 1003–1012. doi: 10.5664/jcsm.3070
76
NaëgeléB.LaunoisS. H.MazzaS.FeuersteinC.PépinJ.-L.LévyP. (2006). Which memory processes are affected in patients with obstructive sleep apnea? An evaluation of 3 types of memory. Sleep29, 533–544. doi: 10.1093/sleep/29.4.533
77
NairD.DayyatE. A.ZhangS. X.WangY.GozalD. (2011a). Intermittent hypoxia-induced cognitive deficits are mediated by NADPH oxidase activity in a murine model of sleep apnea. PLoS One6:e19847. doi: 10.1371/journal.pone.0019847
78
NairD.ZhangS. X.RameshV.HakimF.KaushalN.WangY.et al. (2011b). Sleep fragmentation induces cognitive deficits via nicotinamide adenine dinucleotide phosphate oxidase-dependent pathways in mouse. Am. J. Respir. Crit. Care Med.184, 1305–1312. doi: 10.1164/rccm.201107-1173OC
79
Nakayama-AshidaY.TakegamiM.ChinK.SumiK.NakamuraT.TakahashiK.-I.et al. (2008). Sleep-disordered breathing in the usual lifestyle setting as detected with home monitoring in a population of working men in Japan. Sleep31, 419–425. doi: 10.1093/sleep/31.3.419
80
NeelapuB. C.KharbandaO. P.SardanaH. K.BalachandranR.SardanaV.KapoorP.et al. (2017). Craniofacial and upper airway morphology in adult obstructive sleep apnea patients: a systematic review and meta-analysis of cephalometric studies. Sleep Med. Rev.31, 79–90. doi: 10.1016/j.smrv.2016.01.007
81
NeuzeretP.-C.GormandF.ReixP.ParrotS.SastreJ.-P.BudaC.et al. (2011). A new animal model of obstructive sleep apnea responding to continuous positive airway pressure. Sleep34, 541–548. doi: 10.1093/sleep/34.4.541
82
OhgaE.TomitaT.WadaH.YamamotoH.NagaseT.OuchiY. (2003). Effects of obstructive sleep apnea on circulating icam-1, il-8, and mcp-1. J. Appl. Physiol.94, 179–184. doi: 10.1152/japplphysiol.00177.2002
83
OrrùG.StorariM.ScanoA.PirasV.TaibiR.ViscusoD. (2020). Obstructive sleep apnea, oxidative stress, inflammation and endothelial dysfunction-an overview of predictive laboratory biomarkers. Eur. Rev. Med. Pharmacol. Sci.24, 6939–6948. doi: 10.26355/eurrev_202006_21685
84
PanW.KastinA. J. (2014). Leptin: A biomarker for sleep disorders?Sleep Med. Rev.18, 283–290. doi: 10.1016/j.smrv.2013.07.003
85
Parada VenegasD.De La FuenteM. K.LandskronG.GonzálezM. J.QueraR.DijkstraG.et al. (2019). Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front. Immunol.10:277. doi: 10.3389/fimmu.2019.00277
86
ParkJ.KimM.KangS. G.JannaschA. H.CooperB.PattersonJ.et al. (2015). Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR–S6K pathway. Mucosal Immunol.8, 80–93. doi: 10.1038/mi.2014.44
87
PeñafielF. S.BrockmannV. P.Santín MartínezJ.Fuentes-LópezE.LeivaR. I.ValdiviaC. G. (2019). Performance of sleep questionnaires for the diagnosis of obstructive sleep apnea syndrome. Rev. Med. Chile147, 1543–1552. doi: 10.4067/S0034-98872019001201543
88
PevernagieD. A.Gnidovec-StrazisarB.GroteL.HeinzerR.McnicholasW. T.PenzelT.et al. (2020). On the rise and fall of the apnea−hypopnea index: a historical review and critical appraisal. J. Sleep Res.29:e13066. doi: 10.1111/jsr.13066
89
PoroykoV. A.CarrerasA.KhalyfaA.KhalyfaA. A.LeoneV.PerisE.et al. (2016). Chronic sleep disruption alters gut microbiota, induces systemic and adipose tissue inflammation and insulin resistance in mice. Sci. Rep.6:35405. doi: 10.1038/srep35405
90
PuechC.BadranM.BarrowM. B.RunionA. R.GozalD. (2023). Solriamfetol improves chronic sleep fragmentation-induced increases in sleep propensity and ameliorates explicit memory in male mice. Sleep46:zsad057. doi: 10.1093/sleep/zsad057
91
PuechC.BadranM.RunionA. R.BarrowM. B.QiaoZ.KhalyfaA.et al. (2022). Explicit memory, anxiety and depressive like behavior in mice exposed to chronic intermittent hypoxia, sleep fragmentation, or both during the daylight period. Neurobiol. Sleep Circadian Rhythms13:100084. doi: 10.1016/j.nbscr.2022.100084
92
QiuJ.HellerJ. J.GuoX.ChenZ.-M. E.FishK.FuY.-X.et al. (2012). The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity36, 92–104. doi: 10.1016/j.immuni.2011.11.011
93
QiuX.LiL.WeiJ.AnX.AmpaduJ. A.ZhengW.et al. (2023). The protective role of nrf2 on cognitive impairment in chronic intermittent hypoxia and sleep fragmentation mice. Int. Immunopharmacol.116:109813. doi: 10.1016/j.intimp.2023.109813
94
RameshV.NairD.ZhangS. X.HakimF.KaushalN.KayaliF.et al. (2012). Disrupted sleep without sleep curtailment induces sleepiness and cognitive dysfunction via the tumor necrosis factor-α pathway. J. Neuroinflammation9:91. doi: 10.1186/1742-2094-9-91
95
RivièreA.SelakM.LantinD.LeroyF.De VuystL. (2016). Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front. Microbiol.7:979. doi: 10.3389/fmicb.2016.00979
96
RooksM. G.GarrettW. S. (2016). Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol.16, 341–352. doi: 10.1038/nri.2016.42
97
SapinE.PeyronC.RocheF.GayN.CarcenacC.SavastaM.et al. (2015). Chronic intermittent hypoxia induces chronic low-grade neuroinflammation in the dorsal hippocampus of mice. Sleep38, 1537–1546. doi: 10.5665/sleep.5042
98
SchieferM.GambleJ.BaskinJ.StrohlK. (2020). Hypoglossal nerve stimulation in a rabbit model of obstructive sleep apnea reduces apneas and improves oxygenation. J. Appl. Physiol.129, 442–448. doi: 10.1152/japplphysiol.00828.2019
99
SchizaS. E.MermigkisC.PanagiotisP.BouloukakiI.KallergisE.TzanakisN.et al. (2010). C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy. Eur. J. Clin. Investig.40, 968–975. doi: 10.1111/j.1365-2362.2010.02348.x
100
ShaharE. (2014). Apnea-hypopnea index: time to wake up. Nat. Sci. Sleep6, 51–56. doi: 10.2147/nss.S61853
101
ShiY.GuoX.ZhangJ.ZhouH.SunB.FengJ. (2018). DNA binding protein HMGB1 secreted by activated microglia promotes the apoptosis of hippocampal neurons in diabetes complicated with OSA. Brain Behav. Immun.73, 482–492. doi: 10.1016/j.bbi.2018.06.012
102
ShieuM. M.DunietzG. L.PaulsonH. L.ChervinR. D.BraleyT. J. (2022). The association between obstructive sleep apnea risk and cognitive disorders: a population-based study. J. Clin. Sleep Med.18, 1177–1185. doi: 10.5664/jcsm.9832
103
ShuY.LiuX.YuP.LiH.DuanW.WeiZ.et al. (2022). Inherent regional brain activity changes in male obstructive sleep apnea with mild cognitive impairment: a resting-state magnetic resonance study. Front. Aging Neurosci.14:1022628. doi: 10.3389/fnagi.2022.1022628
104
SmithS. M.FriedleS. A.WattersJ. J. (2013). Chronic intermittent hypoxia exerts CNS region-specific effects on rat microglial inflammatory and TLR4 gene expression. PLoS One8:e81584. doi: 10.1371/journal.pone.0081584
105
SmithP. M.HowittM. R.PanikovN.MichaudM.GalliniC. A.BohloolyY. M.et al. (2013). The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science341, 569–573. doi: 10.1126/science.1241165
106
SnyderB.ShellB.CunninghamJ. T.CunninghamR. L. (2017). Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration. Physiol. Rep.5:e13258. doi: 10.14814/phy2.13258
107
SozerV.KutnuM.AtahanE.Calıskaner OzturkB.HysiE.CabukC.et al. (2018). Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome. Clin. Respir. J.12, 1615–1622. doi: 10.1111/crj.12718
108
SteiropoulosP.KotsianidisI.NenaE.TsaraV.GounariE.HatzizisiO.et al. (2009). Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep32, 537–543. doi: 10.1093/sleep/32.4.537
109
SvatikovaA.WolkR.ShamsuzzamanA. S.KaraT.OlsonE. J.SomersV. K. (2003). Serum amyloid a in obstructive sleep apnea. Circulation108, 1451–1454. doi: 10.1161/01.Cir.0000089091.09527.B8
110
TanA.CheungY. Y.YinJ.LimW.-Y.TanL. W. L.LeeC. H. (2016). Prevalence of sleep-disordered breathing in a multiethnic asian population in Singapore: a community-based study. Respirology21, 943–950. doi: 10.1111/resp.12747
111
TangM. X.LiS.WeiL.HouZ. H.QuJ.LiL. (2021). Do engineered nanomaterials affect immune responses by interacting with gut microbiota?Front. Immunol.12:11. doi: 10.3389/fimmu.2021.684605
112
TegelerC.O'sullivanJ. L.BucholtzN.GoldeckD.PawelecG.Steinhagen-ThiessenE.et al. (2016). The inflammatory markers CRP, IL-6, and IL-10 are associated with cognitive function--data from the berlin aging study II. Neurobiol. Aging38, 112–117. doi: 10.1016/j.neurobiolaging.2015.10.039
113
TehJ. Z.GrummittL.HaroutonianC.CrossN. E.SkinnerB.BartlettD. J.et al. (2023). Overnight declarative memory consolidation and non-rapid eye movement sleep electroencephalographic oscillations in older adults with obstructive sleep apnea. Sleep46:zsad087. doi: 10.1093/sleep/zsad087
114
TichanonP.WilaiwanK.SopidaS.OrapinP.WatcharaB.BanjamasI. (2016). Effect of continuous positive airway pressure on airway inflammation and oxidative stress in patients with obstructive sleep apnea. Can. Respir. J.2016:3107324. doi: 10.1155/2016/3107324
115
TurnbaughP. J.LeyR. E.MahowaldM. A.MagriniV.MardisE. R.GordonJ. I. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature444, 1027–1031. doi: 10.1038/nature05414
116
ValentiniF.EvangelistiM.ArpinelliM.Di NardoG.BorroM.SimmacoM.et al. (2020). Gut microbiota composition in children with obstructive sleep apnoea syndrome: a pilot study. Sleep Med.76, 140–147. doi: 10.1016/j.sleep.2020.10.017
117
VanekJ.PraskoJ.GenzorS.OciskovaM.KantorK.HolubovaM.et al. (2020). Obstructive sleep apnea, depression and cognitive impairment. Sleep Med.72, 50–58. doi: 10.1016/j.sleep.2020.03.017
118
VeaseyS. C.LearJ.ZhuY.GrinspanJ. B.HareD. J.WangS.et al. (2013). Long-term intermittent hypoxia elevates cobalt levels in the brain and injures white matter in adult mice. Sleep36, 1471–1481. doi: 10.5665/sleep.3038
119
VeaseyS. C.RosenI. M. (2019). Obstructive sleep apnea in adults. N. Engl. J. Med.380, 1442–1449. doi: 10.1056/NEJMcp1816152
120
WangG.HuangS.WangY.CaiS.YuH.LiuH.et al. (2019). Bridging intestinal immunity and gut microbiota by metabolites. Cell. Mol. Life Sci.76, 3917–3937. doi: 10.1007/s00018-019-03190-6
121
WangF.LiuQ.WuH.TangT.ZhaoT.LiZ. (2022). The dysbiosis gut microbiota induces the alternation of metabolism and imbalance of Th17/Treg in OSA patients. Arch. Microbiol.204:217. doi: 10.1007/s00203-022-02825-w
122
WangH.LuY.YanY.TianS.ZhengD.LengD.et al. (2019). Promising treatment for type 2 diabetes: fecal microbiota transplantation reverses insulin resistance and impaired islets. Front. Cell. Infect. Microbiol.9:455. doi: 10.3389/fcimb.2019.00455
123
WeiY.LiuY.AyasN.LaherI. (2022). A narrative review on obstructive sleep apnea in China: a sleeping giant in disease pathology. Heart Mind6, 232–241. doi: 10.4103/hm.hm_49_22
124
WrzosekL.MiquelS.NoordineM.-L.BouetS.Chevalier-CurtM. J.RobertV.et al. (2013). Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol.11:61. doi: 10.1186/1741-7007-11-61
125
WuK. M.LinC. C.ChiuC. H.LiawS. F. (2010). Effect of treatment by nasal continuous positive airway pressure on serum high mobility group box-1 protein in obstructive sleep apnea. Chest137, 303–309. doi: 10.1378/chest.09-0936
126
XiaW.JingY.YuanC. (2023). Correlation between obstructive sleep apnea syndrome (OSAS) and cognitive dysfunction in elderly patients with hypertension. J. Integr. Neurosci.22:83. doi: 10.31083/j.jin2204083
127
YanY.ZhengX.LiuG.ShiG.LiC.ChenH.et al. (2024). Gut microbiota-derived cholic acid mediates neonatal brain immaturity and white matter injury under chronic hypoxia. iScience27:109633. doi: 10.1016/j.isci.2024.109633
128
YokoeT.MinoguchiK.MatsuoH.OdaN.MinoguchiH.YoshinoG.et al. (2003). Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation107, 1129–1134. doi: 10.1161/01.cir.0000052627.99976.18
129
YuM. S.JungN. R.ChoiK. H.ChoiK.LeeB. J.ChungY. S. (2014). An animal model of obstructive sleep apnea in rabbit. Laryngoscope124, 789–796. doi: 10.1002/lary.24398
130
ZhengD.LiwinskiT.ElinavE. (2020). Interaction between microbiota and immunity in health and disease. Cell Res.30, 492–506. doi: 10.1038/s41422-020-0332-7
131
ZhuY.FenikP.ZhanG.MazzaE.KelzM.Aston-JonesG.et al. (2007). Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model. J. Neurosci.27, 10060–10071. doi: 10.1523/jneurosci.0857-07.2007
132
ZimmermanM. E.AloiaM. S. (2006). A review of neuroimaging in obstructive sleep apnea. J. Clin. Sleep Med.2, 461–471. doi: 10.5664/jcsm.26665
Summary
Keywords
obstructive sleep apnea, intermittent hypoxia, systematic inflammation, neurocognitive dysfunction, gut microbiota
Citation
Tang M, Wu Y, Liang J, Yang S, Huang Z, Hu J, Yang Q, Liu F and Li S (2024) Gut microbiota has important roles in the obstructive sleep apnea-induced inflammation and consequent neurocognitive impairment. Front. Microbiol. 15:1457348. doi: 10.3389/fmicb.2024.1457348
Received
30 June 2024
Accepted
13 November 2024
Published
06 December 2024
Volume
15 - 2024
Edited by
Jin Song, Capital Medical University, China
Reviewed by
Svetlana Tomic, Osijek Clinical Hospital Center, Croatia
Amélia M. Sarmento, Fernando Pessoa University, Portugal
Updates
Copyright
© 2024 Tang, Wu, Liang, Yang, Huang, Hu, Yang, Liu and Li.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mingxing Tang, Tangstar2013@163.com; Fei Liu, liufei2004phil@126.com; Shuo Li, shuoli@email.szu.edu.cn
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.